osteoporosis

(redirected from Glucocorticoid-induced osteoporosis)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to osteoporosis

abnormal loss of bony tissue resulting in fragile porous bones attributable to a lack of calcium

References in periodicals archive ?
Glucocorticoid-Induced Osteoporosis (GIOP) is reportedly the most common form of secondary osteoporosis.
Pan et al., "Effects of zuogui pill [phrase omitted] on Wnt singal transduction in rats with glucocorticoid-induced osteoporosis," Journal of Traditional Chinese Medicine, vol.
Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.
There are limited fracture data for men and cases involving glucocorticoid-induced osteoporosis.
In the article titled "Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease" [1], there was an error regarding the FRAX[R] tool, which should be clarified as follows.
WASHINGTON -- New American College of Rheumatology recommendations for glucocorticoid-induced osteoporosis prevention and treatment include refinements in risk assessment and treatment.
Glucocorticoid-induced osteoporosis in children: impact of the underlying disease.
It is well known that long-term administration of excessive glucocorticoid (GC) leads to glucocorticoid-induced osteoporosis (GIO), a vital risk factor of the increase in the incidence of bone fracture [1].
Agnusdei et al., "A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis," Osteoporosis International, vol.
American College of Rheumatology 2010 recommendations forthe prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010; 62:1515-1526.
- Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014
Teriparatide is approved to treat populations with osteoporosis at high risk for fracture, including postmenopausal women and men, and men and women with glucocorticoid-induced osteoporosis. High-risk patients include those with osteoporosis and a history of fracture, those with multiple risk factors for fracture, and those who have failed or are intolerant to other available osteoporosis therapy.
Some of the men may have obvious secondary causes, such as glucocorticoid-induced osteoporosis. These men may have chronic obstructive pulmonary disease, inflammatory bowel disease, or a rheumatologic condition requiring oral glucocorticoids.
[USPRwire, Thu Jun 05 2014] GlobalData's clinical trial report, "Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014" provides data on the Glucocorticoid-Induced Osteoporosis clinical trial scenario.
Full browser ?